Cosmix

Vibha Harish is Season 3's most personally health-crisis-transformed wellness founder. Diagnosed with PCOS at 16 (in 2002), she spent years searching for solutions, encountering only "miracle serums" promising overnight fixes and specialists telling her to "just lose weight." Frustrated by the insecurity marketing and band-aid solutions of the wellness industry, she turned to herbalism and ancient Ayurveda in 2016, studying adaptogens and herbs for five years before founding Cosmix."Tired of the insecurity marketing that came along with the instant fixes and band-aid solutions, I turned to herbalism and ancient Ayurveda that looked deeper than just the symptoms. After experiencing the power of adaptogens and herbs, I knew I had to share it with everyone."

Cosmix is India's most comprehensively formulated plant-based adaptogen and superfood wellness brand, producing in-house-manufactured supplements that address root causes of health issues (gut dysfunction, hormonal imbalance, nutritional deficiency, stress) rather than treating symptoms with quick fixes. Every product combines adaptogens, superfoods, and herbal ingredients in proprietary formulations developed by Vibha's team of herbalists and doctors.The dying plant analogy used in the Shark Tank pitch captured the brand philosophy perfectly: when a plant is dying, you do not apply a cream to its leaves; you fix the soil, water, and nutrients at the root. Similarly, when humans face skin, hair, energy, or hormonal issues, the solution is not external products but internal nutritional correction through the right adaptogens and superfoods.

Amount Asked: ₹1 crore Equity Offered: 1% Implied Pre-Money Valuation: ₹100 crore

Vibha and Soorya opened Season 3 Episode 26 with the most elegantly simple product philosophy demonstration of the season: holding up a dying plant and asking the Sharks whether they would apply a cream to revive it, or fix the soil and nutrients at the root. Every Shark immediately understood the metaphor: Cosmix fixes internal health at the root cause rather than applying external band-aids. The pitch revealed a surprise midway: Vibha and Soorya were husband and wife, adding a personal dimension to an already emotionally resonant health-mission pitch. Their PCOS origin story, the five years of herbalism study, and the ₹20 lakh bootstrapped founding gave the pitch authenticity that institutional wellness brands cannot manufacture.

Aman Gupta appreciated the brand and product quality. He made an initial offer but stepped aside when Namita's pharmaceutical expertise alignment became the most strategically compelling option for the founders. Vineeta Singh was interested in the brand's female health positioning, particularly the PCOS and hormonal health product range. She also made an offer but was outbid by Namita's domain expertise alignment. Anupam Mittal asked about the brand's growth trajectory and competitive positioning in the crowded supplement market. He did not make a final competing offer. Azhar Iqubal (guest Shark) was impressed by the founders' story and product quality but did not make a competing offer against Namita's pharmaceutical alignment. Namita Thapar was the most strategically aligned Shark: Emcure Pharmaceuticals' nutraceutical division, women's healthcare expertise, and pharmaceutical-grade quality assurance infrastructure made her the most commercially relevant investor for a plant-based supplement brand seeking national and global scale.

The founders asked ₹1 crore for 1% equity (₹100 crore valuation). After a sequence of offers and counteroffers from multiple Sharks, the final deal settled with Namita Thapar at ₹1 crore for 1% equity plus 1% royalty until ₹1 crore is recouped. The founders achieved their exact original equity ask, adding only a minimal 1% royalty as the concession. Vibha and Soorya chose Namita specifically because her pharmaceutical industry experience and ability to scale the brand globally were the most strategically valuable capabilities for a wellness supplement company's next growth phase.

Vibha Harish and Soorya Jagadish accepted Namita Thapar's offer of ₹1 crore for 1% equity plus 1% royalty until ₹1 crore is recouped, valuing Cosmix at ₹100 crore. The deal brought Emcure Pharmaceuticals' nutraceutical expertise, pharmaceutical-grade quality infrastructure, and global distribution network into India's most rapidly growing plant-based supplement brand, creating the specific strategic partnership needed to scale from a bootstrapped D2C brand to a national and international wellness powerhouse.

"Cosmix is Season 3's most commercially explosive post-Shark Tank success story. The revenue trajectory tells the entire story: ₹5.3 crore (FY23) to ₹24.3 crore (FY24) to ₹51 crore (FY25), with ₹90 crore projected for FY26 and an ARR run rate of ₹100 crore. Profit in FY25 reached ₹17 crore. The growth is almost entirely attributable to the Shark Tank visibility catalyst combined with genuine product quality. In February 2026, Indian FMCG giant Marico Limited acquired a majority stake in Cosmix for ₹375 crore ($41.5 million), valuing the brand at nearly 4x the ₹100 crore Shark Tank valuation within just 2 years. Marico CEO Saugata Gupta stated: ""We foresee immense potential in the wellness and plant-based nutrition space, and Cosmix has already demonstrated deep consumer resonance with its best-in-class, innovative offerings."" ""We started Cosmix to champion clean ingredients and honest communication, creating the kind of wellness products we wanted for ourselves and our community. Partnering with Marico is a defining moment for that mission,"" the founders said."